Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,256,639
  • Shares Outstanding, K 50,608
  • Annual Sales, $ 993,200 K
  • Annual Income, $ 43,380 K
  • 60-Month Beta 0.37
  • Price/Sales 4.32
  • Price/Cash Flow 18.53
  • Price/Book 5.96
Trade HAE with:

Options Overview Details

View History
  • Implied Volatility 34.32% ( +8.21%)
  • Historical Volatility 29.74%
  • IV Percentile 5%
  • IV Rank 13.13%
  • IV High 88.67% on 02/04/22
  • IV Low 26.11% on 12/06/22
  • Put/Call Vol Ratio 39.57
  • Today's Volume 568
  • Volume Avg (30-Day) 105
  • Put/Call OI Ratio 0.69
  • Today's Open Interest 3,110
  • Open Int (30-Day) 3,302

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.79
  • Number of Estimates 4
  • High Estimate 0.83
  • Low Estimate 0.76
  • Prior Year 0.84
  • Growth Rate Est. (year over year) -5.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.09 +11.23%
on 11/14/22
86.58 -3.53%
on 12/01/22
-0.05 (-0.06%)
since 11/07/22
3-Month
71.63 +16.60%
on 09/27/22
86.58 -3.53%
on 12/01/22
+8.91 (+11.94%)
since 09/07/22
52-Week
43.50 +92.00%
on 01/28/22
86.58 -3.53%
on 12/01/22
+29.24 (+53.87%)
since 12/07/21

Most Recent Stories

More News
Haemonetics (HAE) Q2 Earnings Beat Estimates, 2023 View Up

Under the Hospital segment, despite continued macroeconomic, Haemonetics (HAE) meaningfully grows revenues and market share.

HAE : 83.52 (-0.70%)
MMSI : 70.97 (+0.42%)
AMN : 118.83 (+1.04%)
MEDP : 206.67 (+1.45%)
Company News for Nov 8, 2022

Companies In The News Are: HAE, AMG, NI, PLTR.

NI : 27.67 (-0.61%)
HAE : 83.52 (-0.70%)
AMG : 157.96 (-0.02%)
PLTR : 7.07 (+1.14%)
Haemonetics (HAE) Q2 Earnings and Revenues Surpass Estimates

Haemonetics (HAE) delivered earnings and revenue surprises of 18.57% and 8.60%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

HAE : 83.52 (-0.70%)
PETQ : 11.22 (-2.52%)
Haemonetics: Fiscal Q2 Earnings Snapshot

Haemonetics: Fiscal Q2 Earnings Snapshot

HAE : 83.52 (-0.70%)
Haemonetics 2nd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal 2023, which ended October 1, 2022, are...

HAE : 83.52 (-0.70%)
National Vision (EYE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

National Vision (EYE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EYE : 40.11 (+2.58%)
HAE : 83.52 (-0.70%)
Haemonetics (HAE) Earnings Expected to Grow: Should You Buy?

Haemonetics (HAE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HAE : 83.52 (-0.70%)
PODD : 304.89 (+1.64%)
Why Haemonetics (HAE) is Poised to Beat Earnings Estimates Again

Haemonetics (HAE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

HAE : 83.52 (-0.70%)
Centene (CNC) to Post Q3 Earnings: What's in the Cards?

Centene's (CNC) third-quarter results are likely to reflect higher premiums and contract wins enjoyed by its Medicaid business, partly offset by escalating operating expenses.

HUM : 549.18 (+0.52%)
HAE : 83.52 (-0.70%)
CNC : 87.35 (+1.65%)
GMAB : 45.72 (+0.95%)
Is Amphastar Pharmaceuticals (AMPH) Outperforming Other Medical Stocks This Year?

Here is how Amphastar Pharmaceuticals (AMPH) and Haemonetics (HAE) have performed compared to their sector so far this year.

AMPH : 29.50 (+2.36%)
HAE : 83.52 (-0.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood...

See More

Key Turning Points

3rd Resistance Point 87.77
2nd Resistance Point 86.56
1st Resistance Point 85.04
Last Price 83.52
1st Support Level 82.31
2nd Support Level 81.10
3rd Support Level 79.58

See More

52-Week High 86.58
Last Price 83.52
Fibonacci 61.8% 70.12
Fibonacci 50% 65.04
Fibonacci 38.2% 59.96
52-Week Low 43.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar